Liquiritin apioside

Overview

Liquiritin apioside is an orally active inhibitor of TRPV1 receptor. Liquiritin apioside selectively inhibits laryngeal chemoreflex (LCR) and has no significant effect on mechanoreflex (LMR). Liquiritin apioside inhibits LCR by inhibiting reactive oxygen species (ROS) and NADPH oxidase , weakening the interaction between ROS and TRPV1. Liquiritin apioside can be used in the research of respiratory-related diseases.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Research Areas > Inflammation/Immunology

Product Information

• Catalog No.: HY-N1471
• CAS No.: 74639-14-8
• Molecular Formula: C26H30O13
• Molecular Weight: 550.51
• Purity: 99.96%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (4.54 mM); Clear solution
• Availability: In-stock

Source

Original product source